Literature DB >> 2415784

Interspecies chimeras: an experimental approach for studies on embryonic angiogenesis.

H Sariola.   

Abstract

Most studies on the growth of vessels have so far focused on the tumour vascularization or that occurring in the area of inflammation. The mechanisms of embryonic angiogenesis have not been characterized in such a detail and only relatively few experimental studies have been carried out to analyse the origin and development of the embryonic vasculature. It is not known if the vessels develop in situ in each organ rudiment or by invasion of earlier committed vascular cells. Because morphological analyses of in vivo tissues have proved to be unreliable for judging the origin of vascular cells, new methods have been presented. Nuclear differences between of some species can be used to trace the origin of cells in interspecies transplantation experiments. This review presents data on the biology of vasculogenesis and shows how interspecies chimeras can be used in studies on angiogenesis. For example, the transplantation experiments with embryonic kidneys are described in more detail.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415784

Source DB:  PubMed          Journal:  Med Biol        ISSN: 0302-2137


  4 in total

Review 1.  Genetic modification of xenografts.

Authors:  J L Platt
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

Review 2.  Early organogenesis of the kidney.

Authors:  L Saxén; H Sariola
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

Review 3.  Cell and molecular biology of kidney development.

Authors:  Kimberly J Reidy; Norman D Rosenblum
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

4.  Proteomic analysis of embryonic kidney development: Heterochromatin proteins as epigenetic regulators of nephrogenesis.

Authors:  Gry H Dihazi; Olaf Jahn; Björn Tampe; Michael Zeisberg; Claudia Müller; Gerhard A Müller; Hassan Dihazi
Journal:  Sci Rep       Date:  2015-09-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.